Here’s whether BioMarin Pharmaceuticals Inc (BMRN) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+1.89% over 10 days); RSI 53 — healthy momentum range; 3-month momentum positive (+11.6%). Currently 10.5% off its 52-week high. Score: +6/7.
BMRN is in a confirmed uptrend, trading above both its 50-day ($56.35) and 200-day ($56.11) moving averages. An RSI of 53.4 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -0.7% compares to +16.5% for SPY (trailed the market by 17.2%).
$10,000 invested 1 year ago→ $9,928 today
vs. S&P 500 (SPY) — same period trailed market by 17.2%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($56.11)
✓Above 50-day MA ($56.35)
✓RSI(14) neutral zone (30–70) — currently 53.4
✗Positive return (-0.7%)
!Within 10% of period high (−10.5%)
Period Range $59.33
$49.26$66.28
RSI (14) 53.4
0 · OversoldOverbought · 100
Key Metrics
Price$59.33
Period Return-0.7%
Period High$66.28
Period Low$49.26
Drawdown−10.5%
MA-50$56.35
MA-200$56.11
RSI (14)53.4
Avg Volume (30d)1.8M
vs. SPYtrailed by 17.2%
Return Rank#530 of 999
Trend Signals
Price is above the 200-day moving average ($56.11)